These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30506222)

  • 1. Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure.
    Cha DI; Kang TW; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim K
    Eur Radiol; 2019 May; 29(5):2706-2715. PubMed ID: 30506222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The therapeutic outcomes of ultrasound-guided percutaneous radiofrequency therapy for subcardiac liver malignant tumor].
    Zhou YZ; Zhu RL; Ouyang JZ; Yu KL; Wang ZZ; Li QJ; Zhou JX
    Zhonghua Wai Ke Za Zhi; 2020 Oct; 58(10):770-775. PubMed ID: 32993264
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term Therapeutic Outcomes of Radiofrequency Ablation for Subcapsular versus Nonsubcapsular Hepatocellular Carcinoma: A Propensity Score Matched Study.
    Kang TW; Lim HK; Lee MW; Kim YS; Rhim H; Lee WJ; Paik YH; Kim MJ; Ahn JH
    Radiology; 2016 Jul; 280(1):300-12. PubMed ID: 26824711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic radiofrequency ablation of subcardiac hepatocellular carcinoma: a case-control study.
    Schullian P; Johnston EW; Putzer D; Eberle G; Laimer G; Bale R
    Int J Hyperthermia; 2019; 36(1):876-885. PubMed ID: 31462110
    [No Abstract]   [Full Text] [Related]  

  • 5. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study.
    Peng ZW; Lin XJ; Zhang YJ; Liang HH; Guo RP; Shi M; Chen MS
    Radiology; 2012 Mar; 262(3):1022-33. PubMed ID: 22357902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed tomography fluoroscopy-guided radiofrequency ablation following intra-arterial iodized-oil injection for hepatocellular carcinomas invisible on ultrasonographic images.
    Takaki H; Yamakado K; Nakatsuka A; Yamada T; Uraki J; Kashima M; Yamanaka T; Shiraki K; Takei Y; Takeda K
    Int J Clin Oncol; 2013 Feb; 18(1):46-53. PubMed ID: 22016114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RF Ablation Versus Cryoablation for Small Perivascular Hepatocellular Carcinoma: Propensity Score Analyses of Mid-Term Outcomes.
    Cha SY; Kang TW; Min JH; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Park MS
    Cardiovasc Intervent Radiol; 2020 Mar; 43(3):434-444. PubMed ID: 31844951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perivascular versus nonperivascular small HCC treated with percutaneous RF ablation: retrospective comparison of long-term therapeutic outcomes.
    Kang TW; Lim HK; Lee MW; Kim YS; Choi D; Rhim H
    Radiology; 2014 Mar; 270(3):888-99. PubMed ID: 24475820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous radiofrequency ablation for pulmonary metastases from hepatocellular carcinoma: results of a multicenter study in Japan.
    Hiraki T; Yamakado K; Ikeda O; Matsuoka T; Kaminou T; Yamagami T; Gobara H; Mimura H; Kawanaka K; Takeda K; Yamashita Y; Inoue Y; Ogawa T; Nishimura T; Kanazawa S
    J Vasc Interv Radiol; 2011 Jun; 22(6):741-8. PubMed ID: 21531575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
    Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
    Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic radiofrequency ablation of subcapsular hepatocellular carcinomas: risk factors related to a technical failure.
    Ko SE; Lee MW; Min JH; Ahn SH; Rhim H; Kang TW; Song KD; Kim JM; Choi GS; Cha DI; Lim HK
    Surg Endosc; 2022 Jan; 36(1):504-514. PubMed ID: 33523278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma.
    Saviano A; Iezzi R; Giuliante F; Salvatore L; Mele C; Posa A; Ardito F; De Gaetano AM; Pompili M;
    J Vasc Interv Radiol; 2017 Nov; 28(11):1512-1519. PubMed ID: 28734848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small Hepatocellular Carcinoma: Radiofrequency Ablation versus Nonanatomic Resection--Propensity Score Analyses of Long-term Outcomes.
    Kang TW; Kim JM; Rhim H; Lee MW; Kim YS; Lim HK; Choi D; Song KD; Kwon CH; Joh JW; Paik SW; Paik YH; Ahn JH
    Radiology; 2015 Jun; 275(3):908-19. PubMed ID: 25688888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous Dual-Switching Monopolar Radiofrequency Ablation Using a Separable Clustered Electrode: A Preliminary Study.
    Choi TW; Lee JM; Lee DH; Lee JH; Yu SJ; Kim YJ; Yoon JH; Han JK
    Korean J Radiol; 2017; 18(5):799-808. PubMed ID: 28860897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Factors of Treatment Outcomes After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma in the Hepatocaval Confluence: A Propensity Score Matching Analysis.
    Zhou Y; Yuan K; Yang Y; Shan X; Ji Z; Zhou D; Ouyang J; Wang Z; Zhang Q; Zhou J; Li Q
    Acad Radiol; 2023 Sep; 30 Suppl 1():S92-S103. PubMed ID: 37173236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous thermal ablation of subcapsular hepatocellular carcinomas: influence of tumor-surface contact and protrusion on therapeutic efficacy and safety.
    Worakitsitisatorn A; Lu DS; Lee MW; Asvadi NH; Moshksar A; Yuen AD; McWilliams J; Raman SS
    Eur Radiol; 2020 Mar; 30(3):1813-1821. PubMed ID: 31822975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computed Tomography-Guided Percutaneous Cryoablation for ‎ Subcardiac Hepatocellular Carcinoma: Safety, Efficacy, Therapeutic Results and Risk Factors for Survival Outcomes.
    Qi C; Gao H; Zhao Q; Zhang L
    Cancer Manag Res; 2020; 12():3333-3342. PubMed ID: 32494197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation for the treatment of bone metastases from hepatocellular carcinoma.
    Kashima M; Yamakado K; Takaki H; Kaminou T; Tanigawa N; Nakatsuka A; Takeda K
    AJR Am J Roentgenol; 2010 Feb; 194(2):536-41. PubMed ID: 20093621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
    Song KD; Lee MW; Rhim H; Kang TW; Cha DI; Sinn DH; Lim HK
    Radiology; 2018 Sep; 288(3):878-886. PubMed ID: 29916771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ablation therapy of hepatocellular carcinoma: a comparative study between radiofrequency and microwave ablation.
    Vogl TJ; Farshid P; Naguib NN; Zangos S; Bodelle B; Paul J; Mbalisike EC; Beeres M; Nour-Eldin NE
    Abdom Imaging; 2015 Aug; 40(6):1829-37. PubMed ID: 25601438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.